Navigation Links
Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
Date:8/19/2007

RESEARCH TRIANGLE PARK, N.C., Aug. 15 /PRNewswire/ -- Quintiles Transnational Corp. today announced the appointment of Michael Troullis as its Chief Financial Officer, effective immediately. Troullis had been acting CFO since former CFO John Ratliff was appointed Quintiles' Chief Operating Officer last year.

Troullis joined Quintiles in 1992 as Director of Finance, Europe. Prior to his appointment as acting CFO, Troullis was Senior Vice President and Worldwide Controller.

"Mike's financial expertise and deep knowledge of Quintiles and our markets make him the best person to be the fourth CFO in Quintiles' 25-year history," said Dennis Gillings, CBE, Chairman and Chief Executive Officer of Quintiles Transnational. "He has helped put in place the financial systems and controls needed to support Quintiles' growth from a small CRO to being the global leader in helping companies bring medicines to market faster and more efficiently."

Troullis, who will report to Gillings, has a bachelor's degree in Economics from the University of Exeter (England) and is qualified as a United Kingdom Chartered Accountant.

Prior to joining Quintiles, Troullis had a 10-year career with CooperVision, where he held several positions of increasing responsibility, finally as European Finance Director; and six years with KPMG in the United Kingdom.

Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, financial partnering and commercialization for the pharmaceutical, biotechnology and healthcare industries. With about 19,000 employees and offices in more than 50 countries, it is focused on providing customer-centric solutions that are the gold standard of the industry. For more information, please visit the company's Web site at http://www.qtrn.com


'/>"/>
SOURCE Quintiles Transnational Corp.

Copyright©2007 PR Newswire.

Page: 1

Related biology technology :

1. Tech Digest: Inacom; St. Michaels, St. Clares hospitals; Merge eMed; Advanced Data-Comm; Blue Cross and Blue Shield
2. Michael Rosencrance deals with medical overload through human-centric IT
3. Michael J. Fox coming to UW Waisman Center
4. VanderSanden appointed president of AT&T Wisconsin
5. State technology chief endorses IT audit recommendations
6. Fusion 2007: CA chief says IT complexity raises risk
7. Web-Based Learning Developed under new Chief Education Officer
8. Merge files financial reports by market opening
9. Merge fails to file quarterly financial report
10. Financial executives to launch Madison chapter
11. Third Wave Reports Third-Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... The two ... healthcare treatment options for patients. Vironika, a spin out from The Wistar Institute, and ... taking lab space at 3624 Market Street. , Vironika is developing a treatment ...
(Date:1/20/2017)... January 20, 2017 http://www.Financialbuzz.com ... one of leading causes of death worldwide. There were ... number of cancer related deaths increased gradually over time, ... incidence rate of various cancers continues to drive demand ... report by Global Market Insights, Inc. cancer biological therapy ...
(Date:1/19/2017)... 19, 2017  Market Research Future has a half cooked research ... Biopsy is growing rapidly and expected to reach USD 450 Million ... ... Biopsy Market has been assessed as a swiftly growing market and ... in the coming future. There has been a tremendous growth in ...
(Date:1/19/2017)... Jan 19, 2017 Research and Markets ... has announced the addition of the ... - Forecast to 2025" report to their offering. ... The report provides a detailed analysis on current and future market ... 2025, using estimated market values as the base numbers ...
Breaking Biology Technology:
(Date:12/19/2016)... España y TORONTO , 19 de diciembre de ... Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo ... varios tipos de tumor en 2017, con múltiples sitios previstos a ... ... con objetivo en el factor inhibidor de leucemia (LIF), una citoquina ...
(Date:12/16/2016)... 2016 Research and Markets has announced the ... Forecast to 2021" report to their offering. ... The biometric vehicle access system ... CAGR of 14.06% from 2016 to 2021. The market is estimated ... reach 854.8 Million by 2021. The growth of the biometric vehicle ...
(Date:12/15/2016)... Germany , December 15, 2016 ... announced an agreement with NuData Security, an award-winning ... partnership will enable clients to focus on good customer experience, ... protection regulation. ... In order to provide a one-stop fraud prevention suite, ...
Breaking Biology News(10 mins):